ColoTest, a new over-the-counter FIT test that requires one stool sample and offers instant results with no lab testing, is now for sale through local pharmacies CLEVELAND, Feb. 27, 2024 /PRNewswire/ -- Reese Pharmaceutical is expanding its over-the-counter (OTC) diagnostic portfolio with the launch of ColoTest®, an at-home Fecal Immunochemical Test (FIT) that identifies the presence of hidden blood in the stool in support of the early detection of colon cancer or gastrointestinal disorders such as colitis, diverticulitis, and polyps.The FDA-cleared ColoTest is now available for sale through a growing number of pharmacies – just in time for Colorectal Cancer Awareness Month in March..

ColoTest是一种新的非处方FIT测试，需要一份粪便样本，无需实验室测试即可即时获得结果，目前正在当地药店克利夫兰销售，2024年2月27日/新闻专线/--里斯制药公司推出了ColoTest®，这是一种家中粪便免疫化学测试（FIT），正在扩大其非处方（OTC）诊断组合它可以识别粪便中是否存在隐藏的血液，以支持结肠癌或胃肠道疾病（如结肠炎，憩室炎和息肉）的早期发现。FDA批准的ColoTest现在可以通过越来越多的药店销售，正好赶上3月份的结直肠癌宣传月。。

Continue Reading

继续阅读

ColoTest

ColoTest

A recent report by the American Cancer Society revealed a troubling spike in new colon and rectal cancer diagnoses across the US. Nearly double the number of young adults under 55 are being diagnosed with colorectal cancer compared to a decade ago, and colorectal cancer is now the leading cause of cancer deaths in men under the age of 50 (second in women under 50)..

美国癌症协会（American Cancer Society）最近的一份报告显示，美国新诊断的结肠癌和直肠癌数量激增，令人担忧。与十年前相比，55岁以下的年轻人被诊断患有结直肠癌的人数几乎翻了一番，而结直肠癌现在是50岁以下男性癌症死亡的主要原因（50岁以下女性中排名第二）。。

'90% of colon cancer-related deaths are thought to be preventable if caught early, and yet more than 29 million Americans are not screening for it. With colon cancer rates on the rise, it is more important than ever for people to be proactive. We're proud to introduce ColoTest to help meet this challenge by delivering a convenient, affordable, non-invasive screening option that enables people to identify invisible blood in stool, a key warning sign for colorectal cancer, diverticulitis, gastrointestinal disorders, colitis and polyps.

“如果及早发现，90%的结肠癌相关死亡被认为是可以预防的，但仍有2900多万美国人没有进行筛查。随着结肠癌发病率的上升，人们比以往任何时候都更加积极主动。我们很自豪地推出ColoTest来帮助应对这一挑战，它提供了一种方便，实惠，无创的筛查选项，使人们能够识别粪便中看不见的血液，这是结直肠癌，憩室炎，胃肠道疾病，结肠炎和息肉的关键警告标志。

This test is performed in the comfort of your own home with results at home as soon as 1 minute,' said Jeffrey Reese, President, of Reese Pharmaceutical.With a suggested retail price of $19.99, ColoTest 1ct is inexpensive and easy to use. You simply place a sheet of paper from the kit over the toilet to collect a sample, brush a portion into the tube, add the sampler, and wait for a reaction.

瑞斯制药总裁杰弗里·瑞斯（JeffreyReese）说，这项测试是在舒适的家中进行的，最快1分钟就会在家中得到结果。ColoTest 1ct建议零售价为19.99美元，价格低廉且易于使用。您只需将试剂盒中的一张纸放在马桶上收集样本，将一部分刷入试管，添加采样器，然后等待反应。

Results appear in as little as one minute. Those with a positive test are advised to contact their doctor for additional testing, such as a colonoscopy.While colonoscopies remain the gold standard of screening for colorectal cancer, only some people become eligible for the procedure before age 45, with others feeling adverse to colonoscopy or lacking insurance coverage.

结果只需一分钟即可显示出来。建议检测呈阳性的患者联系医生进行其他检测，如结肠镜检查。虽然结肠镜检查仍然是筛查结直肠癌的金标准，但只有一些人在45岁之前才有资格接受结肠镜检查，而其他人则对结肠镜检查感到不利或缺乏保险。

ColoTest offers a highly accurate and discreet alternative that anyone can access regardless of age, which may help get more young adults screened sooner. Reese Pharmaceutical has been serving the pharmaceutical industry for over 100 years with a portfolio of products across cough and cold, digestive care, family planning, feminine health, and first aid. The company received U.S.

ColoTest提供了一个高度准确和谨慎的替代方案，任何人都可以访问，无论年龄大小，这可能有助于更快地筛查更多的年轻人。瑞斯制药（Reese Pharmaceutical）为制药行业服务了100多年，产品涵盖咳嗽感冒、消化保健、计划生育、女性健康和急救。该公司收到了美国。

Food and Drug Administration (FDA) clearance for ColoTest in September 2023. The new test will be on shelves.

食品和药物管理局（FDA）于2023年9月批准了ColoTest。新测试将上架。